Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio?

Amedeo F. Capetti*, Giancarlo Orofino, Laura Paladini, Gaetana Sterrantino, Simona Di Giambenedetto, Giuseppe V. De Socio, Giovanni Cenderello, Maria V. Cossu, Giuliano Rizzardini

*Corresponding author

Research output: Contribution to journal › Article

2 Citations (Scopus)

Abstract

Abstract not available
Original languageEnglish
Pages (from-to)1083-1084
Number of pages2
JournalAIDS
Volume32
Issue number8
DOIs
Publication statusPublished - 2018

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Keywords

  • Immunology
  • Immunology and Allergy
  • Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Access to Document

Other files and links

Fingerprint

Dive into the research topics of 'Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio?'. Together they form a unique fingerprint.
View full fingerprint

Cite this